Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality
- PMID: 11386890
- DOI: 10.1001/archinte.161.11.1413
Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality
Abstract
Background: Non-high-density lipoprotein cholesterol (non-HDL-C) contains all known and potential atherogenic lipid particles. Therefore, non-HDL-C level may be as good a potential predictor of risk for cardiovascular disease (CVD) as low-density lipoprotein cholesterol (LDL-C).
Objectives: To determine whether non-HDL-C level could be useful in predicting CVD mortality and to compare the predictive value of non-HDL-C and LDL-C levels.
Methods: Data are from the Lipid Research Clinics Program Follow-up Study, a mortality study with baseline data gathered from 1972 through 1976, and mortality ascertained through 1995. A total of 2406 men and 2056 women aged 40 to 64 years at entry were observed for an average of 19 years, with CVD death as the main outcome measure.
Results: A total of 234 CVD deaths in men and 113 CVD deaths in women occurred during follow-up. Levels of HDL-C and non-HDL-C at baseline were significant and strong predictors of CVD death in both sexes. In contrast, LDL-C level was a somewhat weaker predictor of CVD death in both. Differences of 0.78 mmol/L (30 mg/dL) in non-HDL-C and LDL-C levels corresponded to increases in CVD risk of 19% and 15%, respectively, in men. In women, differences of 0.78 mmol/L (30 mg/dL) in non-HDL-C and LDL-C levels corresponded to increases in CVD risk of 11% and 8%, respectively.
Conclusions: Non-HDL-C level is a somewhat better predictor of CVD mortality than LDL-C level. Screening for non-HDL-C level may be useful for CVD risk assessment.
Comment in
-
Non-high-density lipoprotein cholesterol level as potential risk predictor and therapy target.Arch Intern Med. 2001 Jun 11;161(11):1379-80. doi: 10.1001/archinte.161.11.1379. Arch Intern Med. 2001. PMID: 11386886 No abstract available.
-
Prediction of cardiovascular mortality.Arch Intern Med. 2002 Jan 14;162(1):108; author reply 109-10. doi: 10.1001/archinte.162.1.108. Arch Intern Med. 2002. PMID: 11784244 No abstract available.
-
The advantages of using non-HDL-C in the diagnosis and treatment of dyslipidemia.Arch Intern Med. 2002 Jan 14;162(1):108-9; author reply 109-10. doi: 10.1001/archinte.162.1.108-a. Arch Intern Med. 2002. PMID: 11784245 No abstract available.
Similar articles
-
Plasma lipoprotein levels as predictors of cardiovascular death in women.Arch Intern Med. 1993 Oct 11;153(19):2209-16. Arch Intern Med. 1993. PMID: 8215724
-
Usefulness of Non-High-Density Lipoprotein Cholesterol as a Predictor of Cardiovascular Disease Mortality in Men in 22-Year Follow-Up.Am J Cardiol. 2017 Apr 15;119(8):1193-1198. doi: 10.1016/j.amjcard.2017.01.008. Epub 2017 Jan 25. Am J Cardiol. 2017. PMID: 28267961
-
Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.Circulation. 2018 Nov 20;138(21):2315-2325. doi: 10.1161/CIRCULATIONAHA.118.034273. Circulation. 2018. PMID: 30571575
-
Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol.J Cardiovasc Pharmacol Ther. 2023 Jan-Dec;28:10742484231189597. doi: 10.1177/10742484231189597. J Cardiovasc Pharmacol Ther. 2023. PMID: 37641208 Review.
-
HDL-C: role as a risk modifier.Atheroscler Suppl. 2011 Nov;12(3):267-70. doi: 10.1016/S1567-5688(11)70885-6. Atheroscler Suppl. 2011. PMID: 22152280 Review.
Cited by
-
Association of Fitness With Incident Dyslipidemias Over 25 Years in the Coronary Artery Risk Development in Young Adults Study.Am J Prev Med. 2015 Nov;49(5):745-752. doi: 10.1016/j.amepre.2015.04.022. Epub 2015 Jul 10. Am J Prev Med. 2015. PMID: 26165197 Free PMC article.
-
Daily White kwao krua dietary supplement alleviates LDL oxidative susceptibility, plasma LDL level and improves vasculature in a hypercholesterolemia rabbit model.J Tradit Complement Med. 2020 May 12;10(5):496-503. doi: 10.1016/j.jtcme.2020.05.001. eCollection 2020 Sep. J Tradit Complement Med. 2020. PMID: 32953566 Free PMC article.
-
Innovatively Established Analysis Method for Lipoprotein Profiles Based on High-Performance Anion-Exchange Liquid Chromatography.J Atheroscler Thromb. 2019 Dec 1;26(12):1027-1040. doi: 10.5551/jat.RV17037. Epub 2019 Sep 20. J Atheroscler Thromb. 2019. PMID: 31548491 Free PMC article. Review.
-
The atherogenic and metabolic impact of non-HDL cholesterol versus other lipid sub-components among non-diabetic and diabetic Saudis.Lipids Health Dis. 2007 Apr 4;6:9. doi: 10.1186/1476-511X-6-9. Lipids Health Dis. 2007. PMID: 17408471 Free PMC article.
-
Using apolipoprotein B to manage dyslipidemic patients: time for a change?Mayo Clin Proc. 2010 May;85(5):440-5. doi: 10.4065/mcp.2009.0517. Mayo Clin Proc. 2010. PMID: 20435837 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical